[Epidemiology of cysticercosis in Madagascar].
By examining the sera from 1,408 healthy individuals in all six provinces of Madagascar with ELISA methods, we were able to demonstrate a very high prevalence for cysticercosis: 18%. The serologic markers for cysticercosis among 1,132 patients with neurologic symptoms was even higher: 36%. Furthermore, of 241 patients with neurocysticercosis, 82% of the serums recognized, in Western Blot test, the 14-20 Kd "evolutivity proteins". Cysticercosis is thus highly implicated in the neurologic syndromes found in Madagascar. Only adequate prophylaxis will permit a reduction in the incidence of this disease.
Unité de Recherches Immunologiques Institut Pasteur Tananarive.
P
P
Michel
P
P
Callies
H
H
Raharison
P
P
Guyon
L
L
Holvoet
C
C
Genin
D000293:Adolescent; D000328:Adult; D000818:Animals; D000909:Antibodies, Helminth / Q000097:blood; D002648:Child; D002675:Child, Preschool; D003551:Cysticercosis / Q000453:epidemiology*; D003552:Cysticercus / Q000276:immunology; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D006801:Humans; D008270:Madagascar / Q000453:epidemiology; D008297:Male; D009422:Nervous System Diseases / Q000469:parasitology
D000909:Antibodies, Helminth
Epidémiologie de la cysticercose à Madagascar.